Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice

Therefore, we demonstrated that Tofacitinib could attenuate atherosclerosis and foam cells formation by inhibiting inflammation and upregulating ABCA1 expression.